Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michael Shamblott

1PUBLICATIONS
17CO-AUTHORS
Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.

Joseph Markowitz, Michael Shamblott, Andrew S Brohl

Pageof 1

Frequent Collaborators

1 joint publications

Joseph Markowitz

1 joint publications

Andrew S Brohl

1 joint publications

Amod A Sarnaik

1 joint publications

Zeynep Eroglu

1 joint publications

Nikhil I Khushalani

1 joint publications

Christopher W Dukes

1 joint publications

Alejandra Chamizo

1 joint publications

Marina Bastawrous

1 joint publications

Edward T Garcia

1 joint publications

Ashraf Dehlawi

Frequent Collaborators

1 joint publications

Joseph Markowitz

1 joint publications

Andrew S Brohl

1 joint publications

Amod A Sarnaik

1 joint publications

Zeynep Eroglu

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.4K
See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.4K
See more related videos